An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Trending
- Too Monsoon? Lil Kim Sparks Word War In Her Support Of LA Fire Relief
- Russian attack kills 4 people in Kyiv
- More than 40 Pakistani migrants feared drowned off African coast
- EV startup Canoo files for bankruptcy and ceases operations
- Amazon suspends US drone deliveries following crash at testing facility
- ChatGPT’s head of product will testify in the US government’s case against Google
- Nelly to perform at President-elect Donald Trump’s inaugural ball
- Jonathan Owens says wife Simone Biles is the ‘better athlete’ in the marriage
Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials
